Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1/2 Open Label, Basket Study to Assess the Safety, Tolerability and Anti-Tumor Activity of Afamitresgene Autoleucel in Pediatric Subjects With MAGE-A4 Positive Tumors

NCT05642455 is registered in ClinicalTrials.gov with USWM CT, LLC as lead sponsor.

NCT NCT05642455
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05642455 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1/2 Open Label, Basket Study to Assess the Safety, Tolerability and Anti-Tumor Activity of Afamitresgene Autoleucel in Pediatric Subjects With MAGE-A4 Positive Tumors
Lead sponsor
USWM CT, LLC
Phase
Phase 1/2
Overall status
Recruiting
Start date
September 1, 2023
Completion date
July 30, 2038
Enrollment
20 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

malignant peripheral nerve sheath tumor (mpnst), neuroblastoma (nbl), osteosarcoma, synovial sarcoma